Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica K Altman

Showing results (51-60 of 166) with videos related to

Pageof 17
Sort By:
Cancer Biology & Therapy|February 6, 2014
Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitorsEdward J Wu, Dennis J Goussetis, Elspeth Beauchamp, et al.
Cancer Research|May 8, 2007
Suppressive effects of statins on acute promyelocytic leukemia cellsAntonella Sassano, Efstratios Katsoulidis, Giovanni Antico, et al.
Human Pathology|February 24, 2020
Unique morphologic and genetic characteristics of acute myeloid leukemia with chromothripsis: a clinicopathologic study from a single institutionJuehua Gao, Yi-Hua Chen, Alain Mina, et al.
Diagnostic Pathology|March 30, 2019
Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall massHaiyan Bao, Juehua Gao, Yi-Hua Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2011
Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitorsJessica K Altman, Antonella Sassano, Surinder Kaur, et al.
Molecular Pharmacology|July 29, 2010
Negative regulatory effects of Mnk kinases in the generation of chemotherapy-induced antileukemic responsesJessica K Altman, Heather Glaser, Antonella Sassano, et al.
Leukemia & Lymphoma|November 30, 2013
Acute myeloid leukemia presenting with panhypopituitarism or diabetes insipidus: a case series with molecular genetic analysis and review of the literatureElizabeth H Cull, Justin M Watts, Martin S Tallman, et al.
American Journal of Hematology|June 8, 2019
Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosisGiacomo Coltro, Terra L Lasho, Christy M Finke, et al.
Oncotarget|April 1, 2015
Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110α subunit of PI3 kinaseMarco Colamonici, Gavin Blyth, Diana Saleiro, et al.
The Journal of Biological Chemistry|February 13, 2009
Activation of protein kinase C{eta} by type I interferonsAmanda J Redig, Antonella Sassano, Beata Majchrzak-Kita, et al.
Pageof 17

Showing results (51-60 of 166) with videos related to

Sort By:
Pageof 17
Cancer Biology & Therapy|February 6, 2014
Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitorsEdward J Wu, Dennis J Goussetis, Elspeth Beauchamp, et al.
Cancer Research|May 8, 2007
Suppressive effects of statins on acute promyelocytic leukemia cellsAntonella Sassano, Efstratios Katsoulidis, Giovanni Antico, et al.
Human Pathology|February 24, 2020
Unique morphologic and genetic characteristics of acute myeloid leukemia with chromothripsis: a clinicopathologic study from a single institutionJuehua Gao, Yi-Hua Chen, Alain Mina, et al.
Diagnostic Pathology|March 30, 2019
Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall massHaiyan Bao, Juehua Gao, Yi-Hua Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2011
Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitorsJessica K Altman, Antonella Sassano, Surinder Kaur, et al.
Molecular Pharmacology|July 29, 2010
Negative regulatory effects of Mnk kinases in the generation of chemotherapy-induced antileukemic responsesJessica K Altman, Heather Glaser, Antonella Sassano, et al.
Leukemia & Lymphoma|November 30, 2013
Acute myeloid leukemia presenting with panhypopituitarism or diabetes insipidus: a case series with molecular genetic analysis and review of the literatureElizabeth H Cull, Justin M Watts, Martin S Tallman, et al.
American Journal of Hematology|June 8, 2019
Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosisGiacomo Coltro, Terra L Lasho, Christy M Finke, et al.
Oncotarget|April 1, 2015
Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110α subunit of PI3 kinaseMarco Colamonici, Gavin Blyth, Diana Saleiro, et al.
The Journal of Biological Chemistry|February 13, 2009
Activation of protein kinase C{eta} by type I interferonsAmanda J Redig, Antonella Sassano, Beata Majchrzak-Kita, et al.
Pageof 17